ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera.
Paola GuglielmelliGiacomo ColtroFrancesco MannelliGiada RotunnoGiuseppe Gaetano LoscoccoCarmela MannarelliChiara MaccariChiara PaoliSimone RomagnoliBartalucci NiccolòAlessandro Maria Maria VannucchiPublished in: Blood advances (2022)
Keyphrases